Navigation Links
For Patients on Statins, Study Finds Filling 90 Day Supply Prescriptions through Mail Service Compared to Retail Pharmacy is Associated with Less Waste
Date:4/27/2011

ST. PAUL, Minn., April 27, 2011 /PRNewswire/ -- A new study shows 90-day statin drug claims filled through a mail service pharmacy are associated with less waste than a 90-day supply from a retail pharmacy. The findings of the study by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, will be presented at the Academy of Managed Care Pharmacy's 23rd Annual Meeting and Showcase, taking place in Minneapolis, Minn. April 27-29.

Waste occurs when patients stop taking their medication, as a result of a dosage or drug switch, before the entire supply is used. Increasingly, patients with chronic conditions are moving to 90-day prescriptions, and previous studies have shown those receiving a 90-day prescription adhere better to their medications compared to those with a 30-day prescription.

"As an increasing number of patients move to 90-day prescriptions, this study shows we have an opportunity to reduce medication waste as a result of a dosage or drug switch if patients fill their prescription through mail service," said Patrick Gleason, PharmD, director of Clinical Outcomes Assessment, Prime.

For the study, researchers reviewed the claims of 51,261 Blue Cross and Blue Shield (BCBS) members who received statin prescriptions to identify those with overlapping claims. Researchers reviewed prescriptions filled from the second quarter of 2009 to the second quarter of 2010, via a retail pharmacy 30-day supply, a retail pharmacy 90-day supply and a mail service 90-day supply.

The results of the study show 3,996 of the 51,261 members (7.8 percent) with a statin claim had at least one day of waste, and the average days of waste was 24. Those receiving a 90-day supply via retail pharmacy had significantly higher waste (p<0.001) than those receiving their prescription through 30-day retail supply or 90-day mail service. Among those who received their medication through 90-day retail supply, those who were unable to use their entire prescription averaged 38.7 days of waste, compared to 35.9 days of waste among those with a 90-day mail service prescription who did not use all of their prescription. In comparison, patients filling a statin prescription via a retail pharmacy 30-day supply who did not use all of their medication averaged 12.4 days of waste.

"Physicians that are prescribing long-term statin medications to patients already established on a drug for chronic cardiovascular disease should consider having their patient fill their prescription via mail service to help reduce medication waste," said Gleason. "For many patients, not only are 90-day mail service supplies associated with reduced waste, they save consumers money and time."

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to nearly 17 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. Many Heart Attack Patients Dont Get Best Emergency Treatment
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):